協會介紹

　　「中華民國學名藥協會」成立於2007年4月18日，為一依法設立、非以營利為目的之社會團體。為配合政府減少整體醫療支出的政策方向，本會在國內製藥界、學術界、研究機構與政府機構單位等各界關心學名藥發展的推動者，傾力支持下成立，希望結合國內產、官、學、研各界，凝聚共識，共同為學名藥產業創造新價值、新商機。

　　本會不定期舉辦相關的座談會、研討會等系列活動，透過國內外專家學者的介紹，使得國人對於學名藥有更進一步的認識與瞭解，讓國人在就醫用藥時知道自己可以有不同的選擇。

　　學名藥協會致力於扮演台灣與國際間製藥界溝通的橋梁，並於2015年正式成為國際學名藥組織會員之一，我們將持續促進台灣與國際間的對話。期望藉由與國際市場的接軌，促進本土製藥業蓬勃發展，提升全球競爭力。


Founded on April 18, 2007, Taiwan Generic Pharmaceutical Association (TGPA) is a legally established and non-profit social organization. In order to proceed with government strategic plan on reducing overall medical expenditure, TGPA was established under the support from academic scholars of the pharmaceutical industry, local government and those who were concerned about the development of pharmaceutical industry. TGPA has been a member of International Generic and Biosimilar Medicines Association (IGBA) since 2015, and our mission is to cultivate the relationship between the pharmaceutical manufacturing industry in Taiwan and global society. 

The mission of TGPA is to enhance dialogue and cooperation among the generic pharmaceutical industry, authorities, and academics in Taiwan. We will hold conferences and forums from time to time to inform the public on the quality and efficiency of generic medicines. To create new values and business opportunities for generic medicines.

TGPA makes an effort to play the role of connecting Taiwan with global generic industry. In 2015, we have been the member of International Generic and Biosimilar Medicines Association (IGBA). TGPA will continue to be an excellent bridge between Taiwan and global generic industry. We hope that the local pharmaceutical industry can enhance competitiveness by connecting with global society. We will do our best to reach the goal.